GeneXpert MTB/RIF Is Superior to BBD Max MDR-TB for Diagnosis of Tuberculosis (TB) in a Country with Low Incidence of Multidrug-Resistant TB (MDR-TB)

E M Mokaddas^{1

2}, S Ahmad³, H S Eldeen²

Affiliations

¹ Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
² Kuwait TB Control Unit, Shuwaikh, Kuwait.
³ Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait Suhail_ah@hsc.edu.kw.

E M Mokaddas et al. J Clin Microbiol. 2019.

. 2019 May 24;57(6):e00537-19.

doi: 10.1128/JCM.00537-19. Print 2019 Jun.

E M Mokaddas^{1

2}, S Ahmad³, H S Eldeen²

¹ Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
² Kuwait TB Control Unit, Shuwaikh, Kuwait.
³ Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait Suhail_ah@hsc.edu.kw.

No abstract available

Keywords: BBD Max MDR-TB; GeneXpert MTB/RIF Ultra; Mycobacterium tuberculosis; performance comparison; rapid diagnosis.

Comment in

Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays.
Murray P, Cooper C, Maus C. Murray P, et al. J Clin Microbiol. 2019 Aug 26;57(9):e00779-19. doi: 10.1128/JCM.00779-19. Print 2019 Sep. J Clin Microbiol. 2019. PMID: 31451572 Free PMC article. No abstract available.
Reply to Murray et al., "Comparative Performance of BD MAX MDR-TB and Cepheid Xpert MTB/RIF Assays".
Mokaddas EM, Ahmad S, Eldeen HS. Mokaddas EM, et al. J Clin Microbiol. 2019 Aug 26;57(9):e00984-19. doi: 10.1128/JCM.00984-19. Print 2019 Sep. J Clin Microbiol. 2019. PMID: 31451575 Free PMC article. No abstract available.

1. World Health Organization. 2018. Global tuberculosis report 2018. WHO/CDS/TB/2018.20. World Health Organization, Geneva, Switzerland.
1. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. 2014. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1:CD009593. doi:10.1002/14651858.CD009593.pub3. - DOI - PMC - PubMed
1. Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, Steingart KR. 2018. Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev 8:CD012768. doi:10.1002/14651858.CD012768.pub2. - DOI - PMC - PubMed
1. Mokaddas E, Ahmad S, Samir I. 2008. Secular trends in susceptibility patterns of Mycobacterium tuberculosis isolates in Kuwait, 1996–2005. Int J Tuberc Lung Dis 12:319–325. - PubMed
1. Ahmad S, Mokaddas E, Al-Mutairi N, Eldeen HS, Mohammadi S. 2016. Discordance across phenotypic and molecular methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a low TB incidence country. PLoS One 11:e0153563. doi:10.1371/journal.pone.0153563. - DOI - PMC - PubMed